Thrombospondin-1 is elevated with both intimal hyperplasia and hypercholesterolemia

Journal of Surgical Research

Volumn 74, Issue 1, 1998, Pages 11-16

  Roth, Jeffrey J ^a   Gahtan, Vivian ^a   Brown, Jeffrey L ^a   Gerhard, Christine ^a   Swami, Vanlila K ^a   Rothman, Vicki L ^a   Tulenko, Thomas N ^a   Tuszynski, George P ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Hypercholesterolemia; Intimal hyperplasia; Thrombospondin 1

Indexed keywords

THROMBOSPONDIN 1;

ANGIOGENESIS; ANGIOPLASTY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; CELL INTERACTION; CONFERENCE PAPER; GENE EXPRESSION; HYPERCHOLESTEROLEMIA; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

EID: 0031845732     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5209     Document Type: Conference Paper

References (39)

1. Consigny P. M., Tulenko T. N., Nicosia R. Acute effects of angioplasty on vascular smooth muscle. Arteriosclerosis. 6:1986;265.
2. Bowen-Pope D. R., Ross R., Seifert R. A. Locally acting growth factors for vascular smooth muscle cells: Endogenous synthesis and release from platelets. Circulation. 72:1985;735.
3. Clowes A. W., Reidy M. A., Clowes M. M. Mechanisms of stenosis after arterial injury. Lab. Invest. 49:1983;208.
4. Baenziger N. L., Brodie G. N., Majerus P. W. Thrombin sensitive protein of human platelet membranes. Proc. Natl. Acad. Sci. USA. 68:1971;240.
5. Lawler J. The structural and functional properties of thrombospondin. Blood. 67:1986;1197.
6. McPherson J., Sage H., Bornstein P. Isolation and characterization of a glycoprotein secreted by aortic endothelial cells in culture. J. Biol. Chem. 256:1981;11330.
7. Majack R. A., Cook S. C., Bornstein P. Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J. Cell. Biol. 101:1985;1059.
8. Jaffe E. A., Ruggiero J. T., Falcone D. J. Monocytes and macrophages synthesize and secrete thrombospondin. Blood. 65:1985;79.
9. Clezardin P. Expression of thrombospondin by cells in culture. Thrombospondin. 1993;41-61.
10. Tuszynski G. P., Rothman V. L., Murphy A., Siegler K., Smith L., Smith S., Karczewski J., Knudsen K. A. Thrombospondin promotes cell substratum adhesion. Science. 236:1987;1570.
11. Majack R. A., Goodman L. V., Dixit V. M. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J. Cell. Biol. 106:1988;415.
12. Taraboletti G., Roberts D., Liotta L. A., Giavazzi R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential angiogenesis regulatory factor. J. Cell. Biol. 111:1990;765.
13. Miano M., Vlasic N., Tota R. R., Stemerman M. B. Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury: A putative in vivo mechanism for autocrine growth. Arterioscler. Thromb. 13:1993;211.
14. Raugi G. J., Mullen J. S., Bark D. H., Okada T., Mayberg M. R. Thrombospondin deposition in carotid artery injury. Am. J. Path. 137:1990;179.
15. Tulenko, T. N. Laury-Kleintop, L. Walter, M. F. Mason, R. P. Cholesterol, calcium and atherosclerosis, Intl. J. Cardiol.
16. Gleason M. M., Medow M. S., Tulenko T. N. Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells. Circ. Res. 69:1991;216.
17. Chen M., Mason R. P., Tulenko T. N. Atherosclerosis alters composition, structure and function of arterial smooth muscle plasma membranes. Biochim. Biophys. Acta. 1272:1995;101.
18. 2+. Arterioscl. Thromb. 14:1994;1854.
19. Tuszynski G. P., Nicosia R. F. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma. Lab. Invest. 70:1994;228.
20. Arnoletti J. P., Albo D., Jhala N., Granick M. S., Solomon M. P., Atkinson B., Rothman V. L., Tuszynski G. P. Computer-assisted image analysis of tumor sections for a new thrombospondin receptor. Am. J. Surg. 168:1994;433.
21. Fanelli C., Aronoff R. Restenosis following coronary angioplasty. Am. Heart J. 119:1990;357.
22. Zierler R. E., Bandyk D. F., Thiele B. L., Strandess D. E. Carotid artery stenosis following endarterectomy. Arch. Surg. 117:1982;1408.
23. Bandyk D. F., Kaebnick H. W., Stewart G. W., Towne J. B. Durability of the in situ saphenous vein arterial bypass: A comparison of primary and secondary patency. J. Vasc. Surg. 5:1987;256.
24. Raugi G. J., Mumby S. M., Abbott-Brown D., Bornstein P. Thrombospondin: Synthesis and secretion by cells in culture. J. Cell. Biol. 95:1982;351.
25. Groves H. M., Kinlough-Rathbone R. L., Mustard J. F. Development of nonthrombogenicity of injured rabbit aortas despite inhibition of platelet adherence. Arteriosclerosis. 6:1986;189.
26. Friedman R. J., Stemerman M. B., Wenz B., Moore S., Gauldie J., Gent M., Tiell M. L., Spaet T. H. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. J. Clin. Invest. 60:1977;1191.
27. Moore S., Friedman R. J., Singal D. P., Gauldie J., Blajchman M. A., Toberts R. S. Inhibition of injury-induced thromboatherosclerotic lesions by antiplatelet serum in rabbits. Thromb. Haemost. 35:1976;70.
28. Goodnight S. H., Coull B. M., McAnulty J. H., Taylor L. M. Antiplatelet therapy: Part 1. West J. Med. 158:1993;385.
29. Green R. M., Roedersheimer L. R., DeWeese J. A. Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency. Surgery. 92:1982;1016.
30. Clyne C. A., Archer T. J., Atuhaire L. K., Chant A. D., Webster J. H. Random control trial of a short course of aspirin and dipyridamole (Persantine) for femorodistal grafts. Br. J. Surg. 74:1987;246.
31. Majack R. A., Cook S. C., Bornstein P. Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J. Cell. Biol. 101:1985;1059.
32. Majack R. A., Mildbrandt J., Dixit V. M. Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. J. Biol. Chem. 262:1987;8821.
33. Ferns G. A. A., Raines E. W., Sprugel K. H., Motani A. S., Reidy M. A., Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 253:1991;1129.
34. Yabkowitz R., Mansfield P. J., Ryan U. S., Suchard S. J. Thrombospondin mediates migration and potentiates platelet-derived growth factor-dependent migration of calf pulmonary artery smooth muscle cells. J. Cell. Physiol. 157:1993;24.
35. Majack R. A., Cook S. C., Bornstein P. Control of smooth muscle cell growth by components of the extracellular matrix: Autocrine role for thrombospondin. Proc. Natl. Acad. Sci. USA. 83:1986;9050.
36. Kobayashi S., Yamamoto T. The molecular biologic study of the expression of thrombospondin in vascular smooth muscle cells and mesangial cells. J. Diab. Comp. 5:1991;121.
37. Majesky M. W. Neointima formation after acute vascular injury: Role of counteradhesive extracellular matrix proteins. Tx. Heart Inst. J. 21:1994;78.
38. Reed M. J., Iruela-Arispe M. L., O'Brien E. R., Truong T., LaBell T., Bornstein P., Sage E. H. Expression of thrombospondins by endothelial cells - Injury is correlated with TSP-1. Am. J. Pathol. 147:1995;1068.
39. Wight T. N., Raugi G. J., Mumby S. M., Bornstein P. Light microscopic immunolocation of thrombospondin in human tissues. J. Histochem. Cytochem. 33:1985;295.